Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma
Clinical trial NCT04460508 · UNKNOWN
Trial details
- NCT number
- NCT04460508
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-20
- Primary completion
- 2022-12-20
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.